Select Medical Holdings Corpora (SEM) concentration risks

The company's disclosed concentration profile has two dimensions: a segment revenue skew and a government payor dependency, both structural in character. The critical illness recovery hospital segment accounted for approximately 45% of total revenue, a moderate-share exposure tied to a specific care setting — long-term acute care hospitals — rather than to any single customer or geography. This is structural because the business model deliberately operates this segment as a core revenue engine, and its share reflects the deliberate portfolio composition rather than an idiosyncratic dependency. Layered on the segment mix is a regulatory payor exposure: revenues from patients covered under the Medicare program represented approximately 29% of total revenue in the most recently cited year, a moderate-share structural exposure. Medicare reimbursement rates, coverage policies, and regulatory criteria for qualifying stays set the financial parameters for a significant portion of the business, and changes in federal healthcare payment policy can affect that revenue without any change in patient volume or care quality. The two exposures interact: the critical illness recovery hospital segment has historically relied on Medicare as a primary payor for long-term acute care, meaning the segment concentration and the payor concentration partially overlap. A Medicare reimbursement reduction would disproportionately affect the largest segment. On balance, both exposures are well-disclosed, widely understood in healthcare sector analysis, and move with federal policy rather than with idiosyncratic counterparty decisions.

For the engine’s reasoning on SEM’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.